Filing Details

Accession Number:
0001213900-19-021420
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-29 20:29:44
Reporting Period:
2019-10-25
Accepted Time:
2019-10-29 20:29:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1733413 Tff Pharmaceuticals Inc. TFFP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1240140 S Robert Mills 2600 Via Fortuna, Suite 360
Austin TX 78746
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-25 5,000 $5.00 5,000 No 4 P Direct
Common Stock Acquisiton 2019-10-29 10,980 $0.00 15,980 No 4 C Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 C Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2019-10-29 10,980 $0.00 10,980 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
184,023 No 4 C Direct
Footnotes
  1. The shares of common stock purchased in the Issuer's initial public offering ("IPO").
  2. The shares of Series A preferred stock automatically converted into the Issuer's common stock upon the completion of the Issuer's IPO at the conversion price of $2.50 per share.
  3. Not Applicable.